Literature DB >> 1454155

The presence of neuropeptides in GABAergic and cholinergic rat cerebrocortical synaptosome sub-populations.

P Foley1, P D Hughes, H F Bradford, M A Ghatei, N Khandanian, S R Bloom.   

Abstract

GABAergic and cholinergic synaptosomes from rat cerebral cortex were isolated by a magnetic immunoaffinity technique, i.e. immunomagnetophoresis. These subpopulations were extracted and subjected to radioimmunoassay for four neuropeptides: Neuropeptide Y (NPY); vasoactive intestinal peptide (VIP); substance P (SP); and somatostatin (SRIF). In each of the sub-populations three of the four peptides were enriched in the sorted fraction compared with the mother fraction with respect to the cytosolic marker lactate dehydrogenase (LDH). In the GABAergic sub-population the order was SP > SRIF > NPY > or = VIP whilst in the cholinergic sub-population they were enriched in the order VIP > or = NPY > SP > SRIF. The presence of NPY has not previously been reported in cortical cholinergic neurons.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454155     DOI: 10.1016/0143-4179(92)90080-g

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  3 in total

Review 1.  Dual-transmitter systems regulating arousal, attention, learning and memory.

Authors:  Sherie Ma; Balázs Hangya; Christopher S Leonard; William Wisden; Andrew L Gundlach
Journal:  Neurosci Biobehav Rev       Date:  2017-07-27       Impact factor: 8.989

2.  Parcellation of cortical areas by in situ hybridization for somatostatin mRNA in the adult rat: frontal, parietal, occipital, and temporal regions.

Authors:  B Garrett; B Finsen; A Wree
Journal:  Anat Embryol (Berl)       Date:  1994-10

3.  The differential release of amino acids and neuropeptides from purified subpopulations of mammalian GABAergic and cholinergic cerebrocortical synaptosomes.

Authors:  P D Hughes; P Foley; H F Bradford; M Ghatei; N Khandanian; S R Bloom; J Y Wu
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.